JP Morgan Chase
RMD icon

JP Morgan Chase’s ResMed RMD Stock Holding History

JP Morgan Chase’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.02M Hold
9,200
– – ﹤0.01% 4089
2025
Q4 		$2.22M Hold
9,200
– – ﹤0.01% 3998
2025
Q3 		$2.52M Hold
9,200
– – ﹤0.01% 3904
2025
Q2 		$2.37M Buy
+9,200
New +$2.19M ﹤0.01% 3775
2025
Q1 		– Sell
-2,500
Closed -$572K – 7663
2024
Q4 		$572K Buy
+2,500
New +$602K ﹤0.01% 4973
2024
Q3 		– Sell
-1,200
Closed -$230K – 7635
2024
Q2 		$230K Hold
1,200
– – ﹤0.01% 5096
2024
Q1 		$238K Buy
+1,200
New +$220K ﹤0.01% 5257
2014
Q4 		– Sell
-90,000
Closed -$4.43M – 4335
2014
Q3 		$4.43M Buy
+90,000
New +$4.58M ﹤0.01% 2441

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase's RMD Position: Q1 2026 in Review

JP Morgan Chase increased its ResMed (RMD) stake by 20% in Q1 2026, buying an estimated $29.8M and bringing the position to 705,147 shares worth $155M. The position accounts for 0.01% of the portfolio, ranked #797.

JP Morgan Chase first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $306M in Q4 2020. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • JP Morgan Chase held 705,147 shares of ResMed worth $155M as of Q1 2026.
  • JP Morgan Chase bought 119,539 ResMed shares in Q1 2026, an estimated $29.8M.
  • ResMed made up 0.01% of JP Morgan Chase's portfolio in Q1 2026, its #797 holding.
  • JP Morgan Chase first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
  • JP Morgan Chase's ResMed position peaked at $306M in Q4 2020.
  • 939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.